ACGIX | VIVAX | ACGIX / VIVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 78 years | 32 years | - |
Gain YTD | 6.709 | 14.000 | 48% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.09B | 195B | 2% |
Annual Yield % from dividends | 1.36 | 2.25 | 61% |
Returns for 1 year | 7.66 | 15.15 | 51% |
Returns for 3 years | -6.18 | 18.25 | -34% |
Returns for 5 years | -3.80 | 41.35 | -9% |
Returns for 10 years | -10.94 | 99.53 | -11% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
THISX | 80.12 | 0.75 | +0.94% |
T. Rowe Price Health Sciences I | |||
IGVWX | 45.76 | 0.35 | +0.77% |
Voya Global High Dividend Low Vol W | |||
PBSRX | 14.89 | 0.05 | +0.34% |
Polen US Small Company Growth Investor | |||
FMEUX | 23.91 | 0.06 | +0.27% |
Franklin Mutual International Value R6 | |||
SINAX | 39.54 | -3.63 | -8.42% |
ClearBridge Large Cap Value A |